Methyl-Cantharidimide (MCA) Has Anticancer Efficacy in ABCB1- and ABCG2-Overexpressing and Cisplatin Resistant Cancer Cells
Yidong Li(The University of Queensland), Zhe‐Sheng Chen(New York College of Traditional Chinese Medicine)
Cited by 11
Related Papers
Microbiota in health and diseases
|Signal Transduction and Targeted Therapy|2022|2.9k
Lapatinib (Tykerb, GW572016) Reverses Multidrug Resistance in Cancer Cells by Inhibiting the Activity of ATP-Binding Cassette Subfamily B Member 1 and G Member 2
|Cancer Research|2008|385
Exploring Phytochemicals for Combating Antibiotic Resistance in Microbial Pathogens
|Frontiers in Pharmacology|2021|271
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
|Drug Resistance Updates|2022|257
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
|Molecular Cancer|2022|129